American College of Cardiology

MARON AND MCKENNA et al., ACC/ESC Expert Consensus Document on Hypertrophic Cardiomyopathy
JACC 2003; 42: 000-000

American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines

Writing Committee Members
BARRY J. MARON, MD, FACC, FESC, Co-Chair; WILLIAM J. MCKENNA, MD, FACC, FESC,* Co-Chair; GORDON K. DANIELSON, MD, FACC; LUKAS J. KAPPENBERGER, MD, FACC, FESC*; HORST J. KUHN, MD, FESC*; CHRISTINE E. SEIDMAN, MD; PRAVIN M. SHAH, MD, MACC; WILLIAM H. SPENCER, III, MD, FACC; PAOLO SPIRITO, MD, FACC, FESC*; FOLKERT J. TEN CATE, MD, PHD, FACC, FESC*; E. DOUGLAS WIGLE, MD, FACC

*Official representatives of the European Society of Cardiology

Task Force Members
ROBERT A. VOGEL, MD, FACC, Chair; JONATHAN ABRAMS, MD, FACC; ERIC R. BATES, MD, FACC; BRUCE R. BRODIE, MD, FACC*; PETER G. DANIAS, MD, PHD, FACC*; GABRIEL GREGORATOS, MD, FACC; MARK A. HLATKY, MD, FACC; JUDITH S. HOCHMAN, MD, FACC; SANJIV KAUL, MBBS, FACC; ROBERT C. LICHTENBERG, MD, FACC; JONATHAN R. LINDNER, MD, FACC; ROBERT A. O’ROURKE, MD, FACC†; GERALD M. POHOST, MD, FACC; RICHARD S. SCHOFIELD, MD, FACC; CYNTHIA M. TRACY, MD, FACC*; WILLIAM L. WINTERS, JR, MD, MACC*

*Former members of Task Force
†Former Chair of Task Force

ESC Committee for Practice Guidelines Members
WERNER W. KLEIN, MD, FACC, FESC, Chair; SILVIA G. PRIORI, MD, PHD, FESC, Co-Chair; ANGELES ALONSO-GARCIA, MD, FACC, FESC; CARINA BLOMSTRO¨ M-LUNDQVIST, MD, PHD, FESC; GUY DE BACKER, MD, PHD, FACC, FESC; JAAP DECKERS, MD, FESC; MARKUS FLATHER, MD, FESC
JAROMIR HRADEC, MD, FESC; ALI OTO, MD, FACC, FESC; ALEXANDER PARKHOMENKO, MD, FESC; SIGMUND SILBER, MD, PHD, FESC; ADAM TORBICKI, MD, FESC

Table of Contents

1. Preamble
2. Introduction
3. General Considerations and Perspectives
4. Nomenclature, Definitions, and Clinical Diagnosis
5. Obstruction to LV Outflow
6. Genetics and Molecular Diagnosis
7. General Considerations for Natural History and Clinical Course
8. Symptoms and Pharmacological Management Strategies
9. Treatment Options for Drug-Refractory Patients
10. Additional Approaches to Relieve Outflow Obstruction and Symptoms
11. Sudden Cardiac Death
12. Atrial Fibrillation
13. References
14. Figures and Tables

When citing this document, the American College of Cardiology Foundation and the European Society of Cardiology would appreciate the following citation format: Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol 2003;42:page-page.

Copies: This document is available on the Web sites of the ACC at www.acc.org and ESC at www.escardio.org. Single copies of this document are available by calling 800-253-4636 (US only) or writing the American College of Cardiology Foundation, Resource Center, 9111 Old Georgetown Road, Bethesda, MD 20814-1699 as well as by calling or writing ESC Guidelines–Reprints, Elsevier Publishers Ltd., 32 Jamestown Road, London, NW17BY, United Kingdom (Tel: _44.207.424.4422; Fax: _44.207.424.4433; Email: gr.davies@elsevier.com.

© 2003 by the American College of Cardiology and the European Society of Cardiology